日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CD38 endows local antigen-specific T(reg) cells with stress resilience for control of compartmentalized CNS inflammation

CD38赋予局部抗原特异性T(reg)细胞应激耐受能力,从而控制中枢神经系统局部炎症。

Chen, Hsin-Hsiang; Tyystjärvi, Sofia; Ruiz Navarro, Diego; Kant, Ravi; Groll, Tanja; Wagner, Ingrid; Domínguez Moreno, Helena; Bonafonte-Pardàs, Irene; Öllinger, Rupert; Afzali, Ali Maisam; Heink, Sylvia; Richter, Lisa Charlotte; Sie, Christopher; Lepennetier, Gildas; Seeholzer, Lea; Steiger, Katja; Merkler, Doron; Rad, Roland; Schotta, Gunnar; Schubert, Benjamin; Muschaweckh, Andreas; Korn, Thomas

CD38 degrades MAVS through mitophagy to inhibit type I interferon secretion in nasopharyngeal carcinoma cells and impairs CD8(+)T cell-mediated anti-tumor immunity

CD38通过线粒体自噬降解MAVS,从而抑制鼻咽癌细胞中I型干扰素的分泌,并削弱CD8(+)T细胞介导的抗肿瘤免疫。

Liang, Lin; Li, Wentao; Liu, Siyi; He, Qian; Zeng, Feng; Cao, Jiaying; Lei, Yan; Li, Yanling; Zhou, Yanhong

Monocyte-mediated metabolic rewiring via CD31-CD38 interactions promotes growth and drug-resistance in multiple myeloma

单核细胞介导的代谢重编程通过 CD31-CD38 相互作用促进多发性骨髓瘤的生长和耐药性。

Raoof, Ramin; Dal Collo, Giada; Simon-Molas, Helga; Tzortzi, Panagiota; Kulaj, Konxhe; Demirez, Elif N; Massaro, Crescenzo; Poels, Renée; Korst, Charlotte L B M; O'Neill, Chloe A; Bruins, Wassilis S C; Broekmans, Marloes E C; Behradkia, Payam; Krevvata, Maria; Zweegman, Sonja; Kater, Arnon P; Baglio, Serena R; Mutis, Tuna; van de Donk, Niels W C J

CD38 expression by neonatal human naive CD4+ T cells shapes their distinct metabolic and tolerogenic properties.

新生儿幼稚 CD4+ T 细胞表达 CD38,从而塑造其独特的代谢和耐受特性。

Dwyer Laura R, DeRogatis Andrea M, Clancy Sean, Gouirand Victoire, Chien Charles, Rogers Elizabeth E, Oltman Scott P, Jelliffe-Pawlowski Laura L, van den Broek Theo, van Wijk Femke, Lynch Susan V, Rutishauser Rachel L, Wagner Allon, Combes Alexis J, Scharschmidt Tiffany C

The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D

七抗耐药性骨髓瘤的演变涉及 CD38、BCMA 和 GPRC5D 的依次丢失。

Riedhammer, C; Truger, M; Lee, H; Leypoldt, L B; Meggendorfer, M; Hutter, S; Müller, H; Mersi, J; Kadel, S K; Buchwald, T; Kosch, R; Helal, M; Afrin, N; Rosenwald, A; Gerhard-Hartmann, E; Brioli, A; Krönke, J; Haferlach, T; Haferlach, C; Weisel, K C; Neri, P; Einsele, H; Kortüm, K M; Waldschmidt, J M; Bahlis, N; Weinhold, N; Rasche, L

Endothelial NAD(+) depletion drives vascular senescence and neuroinflammation via mtDNA-cGAS/STING-CD38 signaling in Alzheimer's disease

内皮细胞NAD(+)耗竭通过mtDNA-cGAS/STING-CD38信号通路驱动阿尔茨海默病中的血管衰老和神经炎症。

Luo, Qing-Hua; Li, Fang; Yang, Li; Pan, Han-Qing; Zhu, Wen-Ping; Hu, Ping; Tao, Chu-Ming; Yin, Min; Zhang, Si; Liao, Qiu-Ye; Chen, Zhi-Hao; Shu, Hong-Xin; Zhu, Xin-Yi; Yan, Teng-Feng; Liu, Xu; Tu, Jiang-Long; Zhu, Xin-Gen

CAR-T cells with the CD38(-)CD73(-)Tim-3(-)HLA-DR(+) phenotype predict the efficacy of tisagenlecleucel as a treatment for B cell precursor ALL.

具有 CD38(-)CD73(-)Tim-3(-)HLA-DR(+) 表型的 CAR-T 细胞可预测 tisagenlecleucel 作为 B 细胞前体 ALL 治疗药物的疗效。

Mikami Takashi, Kato Itaru, Llamas-Covarrubias Mara Anais, Hiramatsu Hidefumi, Uchihara Yoshinori, Mitsuyoshi Takaya, Kitawaki Toshio, Saida Satoshi, Umeda Katsutsugu, Ogawa Seishi, Takaori-Kondo Akifumi, Wing James Badger, Takita Junko

Proinflammatory and cytotoxic CD38(+)HLA-DR(+) effector memory CD8(+) T cells are peripherally expanded in human cardiac allograft vasculopathy

在人类心脏移植血管病变中,促炎性和细胞毒性 CD38(+)HLA-DR(+)效应记忆 CD8(+) T 细胞在外周扩增。

Tada, Yuko; Suthahar, Sujit S A; Roy, Payel; Suryawanshi, Vasantika; Wu, Runpei; Wang, Erpei; Nettersheim, Felix S; Bellapu, Anusha; Dobaczewska, Katarzyna; Kim, Cheryl; Vaida, Florin; Morris, Gerald P; Ley, Klaus; Kim, Paul J

TE-1146, a novel anti-CD38-antibody-lenalidomide conjugate, demonstrates potent ex vivo anti-myeloma activity

TE-1146 是一种新型的抗 CD38 抗体-来那度胺偶联物,表现出强大的体外抗骨髓瘤活性。

Cheng, Shih-Syuan; Jiang, Jing-Gu; Lin, Shih-Chiang; Yu, Yueh-Hsiang; Chang, Tse Wen; Lim, Carmay; Yu, Yuan-Bin; Chu, Hsing-Mao

Assessing the benefit of incorporating an anti-CD38 monoclonal antibody into second- or third-line systemic treatment for patients with relapsed/refractory multiple myeloma: results from the French real-world EMMY study

评估将抗CD38单克隆抗体纳入复发/难治性多发性骨髓瘤患者的二线或三线系统治疗的益处:来自法国真实世界EMMY研究的结果

Chalopin, Thomas; Hulin, Cyrille; Royer, Bruno; Bastie, Jean-Noel; Bobin, Arthur; Merzoug, Karim Belhadj; Macro, Margaret; Karlin, Lionel; Jacquet, Caroline; Mohty, Mohamad; Frenzel, Laurent; Sonntag, Cécile; Fontan, Jean; Rigaudeau, Sophie; Roussel, Murielle; Sanhes, Laurence; Chaoui, Driss; Vincent, Laure; Orfeuvre, Hubert; Bouketouche, Malek; Garlantezec, Ronan; Decaux, Olivier; Perrot, Aurore